VOLITIONRX LTD (VNRX) News Headlines

▮ More

Date

Headline

6/10/2020 9:42:28 AM Cotterford Says Voting Against Volition's Board Proposals At 2020 Annual Meeting

5/22/2020 4:03:23 PM VolitionRx Announces Closing Of $13.8 Mln Public Offering Of Common Stock

5/20/2020 8:47:41 AM VolitionRx Prices Public Offering Of 4.36 Mln Shares At $2.75/Shr

5/19/2020 4:05:42 PM VolitionRx Announces Proposed Underwritten Public Offering Of Common Stock

4/23/2020 8:46:09 AM Volition Files Patent For Nu.Q COVID-19 Triage Test

4/23/2020 8:32:11 AM Volition Files Patent For Nu.Q(TM) COVID-19 Triage Test And Commences Proof Of Concept Studies

2/18/2020 8:30:00 AM Volition Unveils Its Epigenetic Toolbox (Press Release)

10/9/2019 4:13:10 PM Volition Appoints Phillip Barnes To Board Of Directors

9/25/2019 9:34:01 PM 5 Top Gainers In Healthcare Sector Today (OVID, PHAS, TXMD…)

9/24/2019 10:23:04 PM 5 Top Gainers In Healthcare Sector Today (OVID, ZEAL, VCNX…)

9/17/2019 8:37:05 AM VolitionRx Announces Significant Milestone In Its Nu.Q Capture Development Program

7/18/2019 8:32:54 AM VolitionRx Begins Lung Cancer Clinical Study With Fosun Long March In China

7/18/2019 8:30:00 AM VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China (Press Release)

7/10/2019 10:27:03 PM 5 Top Gainers In Healthcare Sector (TRXC, OHRP, VNRX...)

7/10/2019 8:32:21 AM VolitionRx Secures Additional $1.4 Mln In Non-Dilutive Funding

4/9/2019 8:36:03 AM VolitionRx Signs MoU With Texas A&M University For Potential Collaboration To Develop Nu.QTM Veterinary Diagnostics

4/3/2019 8:31:23 AM VolitionRx Limited Extends Clinical Trial Program In Lung Cancer

8/13/2018 9:36:12 PM XBIO To Report Phase 2 Data This Year, VNRX Abuzz, ATRS To Face FDA In Sep

3/13/2018 4:09:09 PM VolitionRx Announces Closing Of $8.4 Mln Public Offering Of Common Stock

3/9/2018 9:11:00 AM VolitionRx Prices $8.4 Mln Public Offering Of Common Stock

Older Articles

Volitionrx Ltd (VNRX)